Literature DB >> 18661923

Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation.

Cinzia Lo Giudice1, Marina Martinengo, Paolo Pietrasanta, Laura Bocciardo, Cristina Malavasi, Simona Rastelli, Maura Faraci, Gino Tripodi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18661923      PMCID： PMC2626849          DOI： 10.2450/2008.0033-07

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  19 in total

Review 1.  Occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

Review 2.  Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Authors:  Winnie Yeo; Philip J Johnson
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

3.  Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.

Authors:  René Gérolami; Mireille Henry; Patrick Borentain; Philippe Colson; Danièle Botta; Catherine Tamalet
Journal:  Clin Infect Dis       Date:  2005-01-21       Impact factor: 9.079

Review 4.  Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.

Authors:  Anna Kempinska; Eun J Kwak; Jonathan B Angel
Journal:  Clin Infect Dis       Date:  2005-09-22       Impact factor: 9.079

5.  Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

Authors:  Chee-kin Hui; Jian Sun; Wing-yan Au; Albert K W Lie; Yui-hung Yueng; Hai-ying Zhang; Nikki P Lee; Jin-ling Hou; Raymond Liang; George K K Lau
Journal:  J Hepatol       Date:  2005-03-31       Impact factor: 25.083

6.  Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.

Authors:  Kiyoshi Kitano; Hikaru Kobayashi; Mayu Hanamura; Kiyoshi Furuta; Mayumi Ueno; Akinori Rokuhara; Eiji Tanaka; Takeji Umemura; Kendo Kiyosawa
Journal:  Eur J Haematol       Date:  2006-09       Impact factor: 2.997

Review 7.  Prophylaxis and treatment of hepatitis B in immunocompromised patients.

Authors:  A Marzano; E Angelucci; P Andreone; M Brunetto; R Bruno; P Burra; P Caraceni; B Daniele; V Di Marco; F Fabrizi; S Fagiuoli; P Grossi; P Lampertico; R Meliconi; A Mangia; M Puoti; G Raimondo; A Smedile
Journal:  Dig Liver Dis       Date:  2007-03-26       Impact factor: 4.088

8.  Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection.

Authors:  Masahiro Onozawa; Satoshi Hashino; Koh Izumiyama; Kaoru Kahata; Makoto Chuma; Akio Mori; Takeshi Kondo; Nobuyasu Toyoshima; Shuichi Ota; Sumiko Kobayashi; Shuhei Hige; Tomomi Toubai; Junji Tanaka; Masahiro Imamura; Masahiro Asaka
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

9.  Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen.

Authors:  A L Mason; L Xu; L Guo; M Kuhns; R P Perrillo
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc.

Authors:  N Dhédin; C Douvin; M Kuentz; M F Saint Marc; O Reman; C Rieux; F Bernaudin; F Norol; C Cordonnier; D Bobin; J M Metreau; J P Vernant
Journal:  Transplantation       Date:  1998-09-15       Impact factor: 4.939
View more
  7 in total

Review 1.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

2.  Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy.

Authors:  Mohamed H Emara; Nahla E El-Gammal; Lamiaa A Mohamed; Maged M Bahgat
Journal:  Virol J       Date:  2010-11-17       Impact factor: 4.099

3.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

4.  Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.

Authors:  Tara N Palmore; Neeral L Shah; Rohit Loomba; Brian B Borg; Uri Lopatin; Jordan J Feld; Farooq Khokhar; Glen Lutchman; David E Kleiner; Neal S Young; Richard Childs; A John Barrett; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-01       Impact factor: 11.382

5.  Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital.

Authors:  A K Sood; Chetan Pangotra; Manish Manrai
Journal:  Med J Armed Forces India       Date:  2016-04-18

6.  Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B.

Authors:  Anitha Madhavan; Arun Sachu; Anu Kumar Balakrishnan; Sobha Balakrishnan; Jayalakshmi Vasudevapanicker
Journal:  J Lab Physicians       Date:  2021-05-19

Review 7.  Update on occult hepatitis B virus infection.

Authors:  Manoochehr Makvandi
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.